Folic acid supplementation for 3 wk reduces pulse pressure and large artery stiffness independent of MTHFR genotype | Zendy

Carolyn Williams | Zendy; Bronwyn A. Kingwell | Zendy; Kevin Burke | Zendy; Jane McPherson | Zendy; Anthony M. Dart | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Folic acid supplementation for 3 wk reduces pulse pressure and large artery stiffness independent of MTHFR genotype

Author(s) -

Carolyn Williams,

Bronwyn A. Kingwell,

Kevin Burke,

Jane McPherson,

Anthony M. Dart

Publication year - 2005

Publication title -

american journal of clinical nutrition

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.608

H-Index - 336

eISSN - 1938-3207

pISSN - 0002-9165

DOI - 10.1093/ajcn.82.1.26

Subject(s) - methylenetetrahydrofolate reductase , medicine , blood pressure , arterial stiffness , crossover study , placebo , homocysteine , pulse pressure , endocrinology , ambulatory blood pressure , cardiology , genotype , chemistry , biochemistry , pathology , alternative medicine , gene

Folic acid reduces plasma homocysteine and may be an important therapy for preventing cardiovascular disease. A key mechanism may be the reduction of arterial stiffness.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research